Search Result "myelodysplasticsyndrome"


Intramolecular Processes and Their Applications in Prodrugs Approaches- Experimental and Computational Studies

Journal: Current Organic Chemistry
Volume: 20 Issue: 3 Year: 2016 Page: 289-315
Author(s): Rafik Karaman,Salma Jumaa,Heba Awwadallah,Samya Salah,Yahya Khawaja,Donia Karaman

General Review Article

Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory Drugs

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 19 Issue: 1 Year: 2019 Page: 51-78
Author(s): Ota Fuchs

Editorial [Hot Topic:Strategies for Molecular-Based Treatment of Hematological Malignancies (Guest Editor: Per Ole Iversen)]

Journal: Current Drug Targets
Volume: 6 Issue: 6 Year: 2005 Page: 629-629
Author(s): Per O. Iversen

Induced Pluripotent Stem Cells

Ebook: Omics Technologies for Clinical Diagnosis and Gene Therapy: Medical Applications in Human Genetics
Volume: 1 Year: 2022
Author(s):
Doi: 10.2174/9789815079517122010016

The Tumor Microenvironment Mediated Signaling Pathways in the Progression of Acute Myeloid Leukemia

Ebook: Advances in Cancer Signal Transduction and Therapy
Volume: 1 Year: 2020
Author(s): Anup S. Pathania,Rachel Weber,Kishore B. Challagundla
Doi: 10.2174/9789811458118120010010

Role of Immunomodulatory Drugs in the Treatment of Lymphoid and Myeloid Malignancies

Ebook: Frontiers in Clinical Drug Research: Hematology
Volume: 3 Year: 2018
Author(s): Ota Fuchs
Doi: 10.2174/9781681083674118030005

Research Article

The Diagnostic Value of Abnormal Bone Marrow Signal Changes on MagneticResonance Imaging: Is Bone Marrow Biopsy Essential?

Journal: Current Medical Imaging
Volume: 20 Issue: 1 Year: 2024 Page: 1-6
Author(s):

Review Article

Targeting Mutant-p53 for Cancer Treatment: Are We There Yet?

Journal: Current Molecular Pharmacology
Volume: 17 Issue: 1 Year: 2024 Page: 1-16
Author(s): Dhi Vya Lim,Wei Hwei Woo,Jing Xuan Lim,Xin Yee Loh,Hui Ting Soh,Seng Yung Adrian Lim,Zheng Yang Lee,Hui Yin Yow,Sharina Binti Hamzah,Jhi Biau Foo

Second-Generation Protein Kinase Inhibitor – A Focus on Quizartinib, A Promising Targeted Therapy for High-Risk FLT3+ Patients with Acute Myeloid Leukemia

Ebook: Frontiers in Clinical Drug Research - Anti-Cancer Agents
Volume: 5 Year: 2019
Author(s): Xavier Thomas,Etienne Paubelle
Doi: 10.2174/9789811405150119050003

Research Article

PF-04449913 Inhibits Proliferation and Metastasis of Colorectal Cancer Cells byDown-regulating MMP9 Expression through the ERK/p65 Pathway

Journal: Current Molecular Pharmacology
Volume: 17 Issue: 1 Year: 2024 Page: 1-13
Author(s):

Previous   Next

Go To   Results 1 - 1 of 19

Apply Filters

Volume Years
Article Type
    Publication Title
      Subject Title

Content Type


Ads
© 2024 Bentham Science Publishers | Privacy Policy